This Article Full Text Full Text (PDF) All Versions of this Article: 147/4/1979    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuller, K. Articles by Chambers, T. J. Search for Related Content PubMed PubMed Citation Articles by Fuller, K. Articles by Chambers, T. J.

Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents

Department of Cellular and Molecular Medicine, St. George’s, University of London, London SW17 0RE, United Kingdom

Address all correspondence and requests for reprints to: Dr. Timothy J. Chambers, Department of Cellular and Molecular Medicine, St. George’s, University of London, Cranmer Terrace, London SW17 0RE, United Kingdom. E-mail: tchamber{at}sgul.ac.uk.

Although much has been learned recently of the mechanisms that regulate osteoclastic differentiation, much less is known of the means through which their resorptive activity is controlled. We have developed an assay that allows us to measure resorptive activity while minimizing the confounding effects of the test agent on differentiation. In this assay, murine osteoclasts were harvested from plastic substrates and sedimented onto bone slices in MEM with 10% fetal calf serum. The majority excavate the bone surface within a few hours. We found that the regulation of resorption was distinct from that of osteoclastogenesis. Thus, interferons-ß and -, which strongly suppress, and TGFß, which potently stimulates osteoclast differentiation, were without effect on resorption, whereas IL-1, which does not induce osteoclastogenesis, was a strikingly potent stimulus for bone resorption. TNF and IL-1 were able to replace receptor activator of nuclear factor-B ligand for stimulation of bone resorption. Protons stimulated bone resorption only in the presence of a resorptive stimulus. PTH, IL-6, and antibodies against osteoclast-associated receptor did not affect bone resorption. Resorption was potently suppressed by 20 mM calcium, 10 µM cyclosporin A, 1 ng/ml calcitonin, and 1 mM dibutyryl cAMP and cGMP. These results show that full functional differentiation of osteoclasts does not require a signal from bone matrix but can occur on plastic and that osteoclastic differentiation and function are regulated by distinct agents.

This article has been cited by other articles:

				K. Kim, S.-H. Lee, J. Ha Kim, Y. Choi, and N. Kim NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Mol. Endocrinol., January 1, 2008; 22(1): 176 - 185. [Abstract] [Full Text] [PDF]

				S. L. Teitelbaum Osteoclasts: What Do They Do and How Do They Do It? Am. J. Pathol., February 1, 2007; 170(2): 427 - 435. [Abstract] [Full Text] [PDF]

				Q. Zhong, T. Itokawa, S. Sridhar, K.-H. Ding, D. Xie, B. Kang, W. B. Bollag, R. J. Bollag, M. Hamrick, K. Insogna, et al. Effects of glucose-dependent insulinotropic peptide on osteoclast function Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E543 - E548. [Abstract] [Full Text] [PDF]